CONMED CORPORATION Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31)
CONMED CORPORATION (CNMD) had Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31) of $7.50 million as of 2012-12-31, per its 10-K filed 2013-02-25.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear · last filed 2013-02-25
- 2012-12-31: Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31) $7.50M.
- 2012-09-30: Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31) $1.40M.
- 2012-06-30: Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31) $2.00M.
- 2012-03-31: Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31) $2.70M.
| Period end | Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year (Deprecated 2013-01-31) |
|---|---|
| 2012-12-31 | $7.50M 10-K · filed 2013-02-25 |
| 2012-09-30 | $1.40M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $2.00M 10-Q · filed 2012-07-30 |
| 2012-03-31 | $2.70M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $2.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |